Design and Development of Long Circulating Liposomal Daunorubicin for In Vivo Targeting of Solid Tumors: DaunoXome®

  • Forssen E
  • Proffitt R
N/ACitations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This chapter reviews the formulation research, development, and characterization of a tumor-targeting daunorubicin liposome preparation with a long circulating half-life (DaunoXome®). The identification of liposome formulations capable of delivering their...

Cite

CITATION STYLE

APA

Forssen, E. A., & Proffitt, R. T. (1998). Design and Development of Long Circulating Liposomal Daunorubicin for In Vivo Targeting of Solid Tumors: DaunoXome®. In Long Circulating Liposomes: Old Drugs, New Therapeutics (pp. 73–96). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-22115-0_6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free